These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21665542)

  • 21. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
    Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
    Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
    Fauser BC; Diedrich K; Devroey P;
    Hum Reprod Update; 2008; 14(1):1-14. PubMed ID: 18006561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild ovarian stimulation for IVF: 10 years later.
    Fauser BC; Nargund G; Andersen AN; Norman R; Tarlatzis B; Boivin J; Ledger W
    Hum Reprod; 2010 Nov; 25(11):2678-84. PubMed ID: 20858698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of two doses of recombinant human luteinizing hormone supplementation in down-regulated women of advanced reproductive age undergoing follicular stimulation for IVF: a randomized clinical study.
    Fábregues F; Iraola A; Casals G; Creus M; Carmona F; Balasch J
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):56-61. PubMed ID: 21600688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteinizing hormone add-back: is it needed in controlled ovarian stimulation, and if so, when?
    Griesinger G; Shapiro DB
    J Reprod Med; 2011; 56(7-8):279-300. PubMed ID: 21838158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization.
    Kovacs P; Kovats T; Kaali SG
    Fertil Steril; 2010 Feb; 93(2):475-9. PubMed ID: 19200991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.
    Vlaisavljević V; Meden-Vrtovec H; Lewandowski P; Radwan M; Langerova A; Vicena M; Války J; Herman M; Usoniene A; Treijs G
    Curr Med Res Opin; 2010 Apr; 26(4):819-25. PubMed ID: 20121657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
    La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
    Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
    Singer T; Barad DH; Weghofer A; Gleicher N
    Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
    Selman H; Pacchiarotti A; El-Danasouri I
    Fertil Steril; 2010 Oct; 94(5):1782-6. PubMed ID: 19939369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormone determination in the management and monitoring of cycles of medically-assisted reproductive technology: value and difficulties of use].
    Taieb J; Benattar C; Poüs C
    Ann Biol Clin (Paris); 2003; 61(5):533-40. PubMed ID: 14671750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.
    Ferraretti AP; La Marca A; Fauser BC; Tarlatzis B; Nargund G; Gianaroli L;
    Hum Reprod; 2011 Jul; 26(7):1616-24. PubMed ID: 21505041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forty years of IVF.
    Niederberger C; Pellicer A; Cohen J; Gardner DK; Palermo GD; O'Neill CL; Chow S; Rosenwaks Z; Cobo A; Swain JE; Schoolcraft WB; Frydman R; Bishop LA; Aharon D; Gordon C; New E; Decherney A; Tan SL; Paulson RJ; Goldfarb JM; Brännström M; Donnez J; Silber S; Dolmans MM; Simpson JL; Handyside AH; Munné S; Eguizabal C; Montserrat N; Izpisua Belmonte JC; Trounson A; Simon C; Tulandi T; Giudice LC; Norman RJ; Hsueh AJ; Sun Y; Laufer N; Kochman R; Eldar-Geva T; Lunenfeld B; Ezcurra D; D'Hooghe T; Fauser BCJM; Tarlatzis BC; Meldrum DR; Casper RF; Fatemi HM; Devroey P; Galliano D; Wikland M; Sigman M; Schoor RA; Goldstein M; Lipshultz LI; Schlegel PN; Hussein A; Oates RD; Brannigan RE; Ross HE; Pennings G; Klock SC; Brown S; Van Steirteghem A; Rebar RW; LaBarbera AR
    Fertil Steril; 2018 Jul; 110(2):185-324.e5. PubMed ID: 30053940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.